GT Healthcare Capital Partners
Asia, Hong Kong Island, Hong Kong, Central'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
GT Healthcare Capital Partners specializes in healthcare investments around the globe that aim to change technology landscapes.
Investor Profile
GT Healthcare Capital Partners has backed more than 19 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 11% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, France.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series C (26%)
- Series A (26%)
- Series B (16%)
- Series Unknown (11%)
- Seed (11%)
- Series D (5%)
- Private Equity (5%)
Country Focus
- United Kingdom (53%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- United States (37%)
- France (11%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Therapeutics
- Artificial Intelligence (Ai)
- Medical
- Pharmaceutical
- Medical Device
- Oncology
- Nanotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
